Looking for a Cheaper Alternative to Mounjaro? Here's the Honest Picture

Why does Mounjaro cost what it does in the UK private market?

Mounjaro's UK private price rose sharply after Eli Lilly revised its list pricing from 1 September 2025. Before that change, the highest-dose pen was typically listed at around £122; since then, reported private prices across the market have ranged from roughly £149 to £375 per month depending on dose and provider. Those figures are widely cited in the financial and pharmacy press, though individual prices shift, so treat them as context rather than a fixed quote.

The dose matters more than most people realise. Treatment starts at 2.5 mg (a low-dose period designed to let your system adjust before titration begins) and can reach 15 mg. The later, higher doses are the more expensive ones, so the monthly figure you see advertised for the starter phase will not be what you pay further into treatment. Our Mounjaro price breakdown covers how costs shift as the dose increases.

None of this makes Mounjaro unreasonably priced for what it is: a clinically reviewed, prescription medicine from a licensed UK supply chain, dispensed by a GPhC-registered pharmacy. The list price reflects that, and it means any quote significantly below the reported market range deserves scrutiny, not celebration. If you are weighing up your options after the pricing changes, our page on Mounjaro price increase alternatives sets out the choices worth considering.

What do headline 'cheaper Mounjaro alternative' prices usually miss?

When people search for a cheaper Mounjaro alternative, they often land on headline prices that strip out several real costs. A few things worth checking before comparing:

Consultation fees are common. Many providers charge separately for the clinical assessment required by law before any prescription-only medicine can be issued. Add that to the pen price and the gap with a more transparent all-in quote narrows quickly.

Prescription fees are another line item. Some pharmacies charge for issuing the prescription itself on top of the medicine cost. Delivery is a third: next-day tracked delivery for a temperature-sensitive medicine is not free to provide, and not every provider absorbs it.

Aftercare and dose-review support vary enormously. Being able to reach a clinical team seven days a week (and having every repeat order reviewed by a real prescriber rather than processed automatically) has a cost. Providers who don't offer it can price lower. Whether that represents a saving worth making is a different question.

If you want to understand the full picture of what drives UK pricing across the market, the page on Mounjaro injection pricing goes into more detail. For a practical guide to getting Mounjaro cheaper without cutting corners on safety or clinical oversight, we have put together a dedicated breakdown of what actually moves the needle on cost.

Where does Wegovy sit as an alternative, and does it actually cost less?

Wegovy (semaglutide) is the other licensed injectable weight-loss medicine available privately in the UK, and it is the most commonly cited alternative to Mounjaro. It works via a single pathway (GLP-1 receptor agonism) compared to Mounjaro's dual GIP and GLP-1 mechanism. In a head-to-head clinical trial (SURMOUNT-5, published in the New England Journal of Medicine in 2025), tirzepatide produced greater average weight reduction than semaglutide 2.4 mg over 72 weeks. That said, both medicines produce meaningful results for many people, as the weight-loss treatment overview explains, and the right choice is a clinical one, not a price one.

On cost: Wegovy's private price also varies by provider and dose. At lower doses it can appear cheaper, but as with Mounjaro, the relevant comparison is the full-cost-of-treatment picture, not the opening-month pen price. If you are wondering where to buy Mounjaro cheaper from a legitimate, GPhC-registered provider, our guide walks through which factors to compare and what to watch out for. A NICE appraisal (TA875) recommends semaglutide for weight management on the NHS, but typically through specialist services with waiting lists that are commonly long.

There is also now an oral option: the Wegovy tablet (oral semaglutide) received MHRA approval in June 2026 as the first oral GLP-1 medicine licensed in the UK for weight management. It reaches a 25 mg maintenance dose taken once daily and removes the need for injections entirely. Whether it fits your situation is something our prescribers can discuss at consultation, see our treatment options page for what nume currently offers.

Is 'cheapest' actually the right question to ask about a prescription medicine?

Here is the honest answer: for a prescription-only medicine, the price comparison answers the wrong question. The right question is whether the supply chain is legitimate, the clinical oversight is real and the pharmacy is GPhC-registered. You can verify any online pharmacy on the GPhC pharmacy register before handing over a payment.

The MHRA has warned publicly about counterfeit weight-loss pens sold online and through social media, some fake pens have contained insulin, leading to hospitalisations. Enforcement in 2025 included the seizure of around 20 million doses of illegally traded weight-loss medicines (roughly £45 million in street value) and the raid of a UK site producing counterfeit tirzepatide pens. Sellers offering these medicines without a prescription, at prices far below the reported market, or via social media accounts are the pattern to avoid.

At nume, we are deliberately not the cheapest option on the market. One transparent price covers consultation, prescription, treatment, next-working-day DPD delivery and seven-day aftercare, no extras appear at checkout. Every repeat order is clinically re-reviewed by a GPhC-registered prescriber; nothing is processed automatically. If you order before midday on a working day and your consultation is approved, your treatment leaves our pharmacy the same day. Our clinical team and pharmacy registration details are published openly, GPhC premises registration 9012878, verifiable at pharmacyregulation.org.

If you would like to explore whether Mounjaro, Wegovy or the Wegovy tablet suits your situation, and see current treatment pricing in one place, you can check your eligibility with a free consultation, reviewed the same day by a real clinician, not software. And if you are curious whether Mounjaro's pricing is likely to shift, the page on whether Mounjaro will get cheaper covers what we know.